BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 16324253)

  • 1. [Expression of DNA methyltransferase 1, 3A and 3B mRNA in the epithelial ovarian carcinoma].
    Chen CL; Yan X; Gao YN; Liao QP
    Zhonghua Fu Chan Ke Za Zhi; 2005 Nov; 40(11):770-4. PubMed ID: 16324253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms.
    Wang P; Wu X; Chen W; Liu J; Wang X
    Gynecol Oncol; 2007 Mar; 104(3):714-20. PubMed ID: 17204312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells.
    Ahluwalia A; Hurteau JA; Bigsby RM; Nephew KP
    Gynecol Oncol; 2001 Aug; 82(2):299-304. PubMed ID: 11531283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers.
    Xiong Y; Dowdy SC; Xue A; Shujuan J; Eberhardt NL; Podratz KC; Jiang SW
    Gynecol Oncol; 2005 Mar; 96(3):601-9. PubMed ID: 15721400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and clinical significance of endostatin and vascular endothelial growth factor in ovarian carcinoma].
    Shi HR; Song WJ; Chen ZM; Wu QH
    Ai Zheng; 2005 Sep; 24(9):1127-31. PubMed ID: 16159439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer.
    Jung YW; Kim YT; Kim SW; Kim S; Kim JH; Cho NH; Kim JW
    Reprod Sci; 2009 Nov; 16(11):1103-11. PubMed ID: 19692629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Human pituitary tumor transforming gene 1 expression in ovarian carcinoma and its clinical significance].
    Cheng YX; Feng J; Zhang XY; Fu TY; Yao Y
    Ai Zheng; 2004 Sep; 23(9):1026-30. PubMed ID: 15363195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
    Oh BK; Kim H; Park HJ; Shim YH; Choi J; Park C; Park YN
    Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.
    Girault I; Tozlu S; Lidereau R; Bièche I
    Clin Cancer Res; 2003 Oct; 9(12):4415-22. PubMed ID: 14555514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma.
    Gorovetz M; Baekelandt M; Berner A; Trope' CG; Davidson B; Reich R
    Gynecol Oncol; 2006 Dec; 103(3):831-40. PubMed ID: 16919315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated mRNA levels of DNA methyltransferase-1 as an independent prognostic factor in primary nonsmall cell lung cancer.
    Kim H; Kwon YM; Kim JS; Han J; Shim YM; Park J; Kim DH
    Cancer; 2006 Sep; 107(5):1042-9. PubMed ID: 16888795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on mRNA expression of the human novel gene NM23-H1B in ovarian tumor].
    Li W; Liu Y; Jin ZJ; Feng YJ; Huang LM; Chen J
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):48-51. PubMed ID: 16635329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin expression in ovarian cancer.
    Liguang Z; Peishu L; Hongluan M; Hong J; Rong W; Wachtel MS; Frezza EE
    Exp Oncol; 2007 Jun; 29(2):121-5. PubMed ID: 17704744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
    Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
    Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of dihydrodiol dehydrogenase is associated with cisplatin-based chemotherapy resistance in ovarian cancer patients.
    Chen YJ; Yuan CC; Chow KC; Wang PH; Lai CR; Yen MS; Wang LS
    Gynecol Oncol; 2005 Apr; 97(1):110-7. PubMed ID: 15790446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered mRNA expressions of sialyltransferases in ovarian cancers.
    Wang PH; Lee WL; Juang CM; Yang YH; Lo WH; Lai CR; Hsieh SL; Yuan CC
    Gynecol Oncol; 2005 Dec; 99(3):631-9. PubMed ID: 16112178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.
    Koensgen D; Mustea A; Klaman I; Sun P; Zafrakas M; Lichtenegger W; Denkert C; Dahl E; Sehouli J
    Gynecol Oncol; 2007 Nov; 107(2):266-73. PubMed ID: 17698176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of aFGF and bFGF in ovarian cancer and their effect on ovarian cancer cell proliferation].
    Zhang Y; Shang H; Sun LG; Liu N; Yu HY
    Ai Zheng; 2003 Nov; 22(11):1162-5. PubMed ID: 14613644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between cyclooxygenase-2 protein expression, prostaglandins levels and biologic behavior in ovarian carcinoma tissue].
    Tang L; Wang M; Ma J
    Zhonghua Fu Chan Ke Za Zhi; 2002 Nov; 37(11):687-90. PubMed ID: 12487927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of KiSS-1, matrix metalloproteinase-9, nuclear factor-kappaBp65 in ovarian tumour].
    Gao GL; Liu LD; Zou XS; Chen WX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):34-8. PubMed ID: 17331419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.